Wednesday, September 16, 2026Latest filing Sep 14, 2026

PCVX Congressional Stock Trades

Vaxcyte, Inc. - Common Stock (PCVX)

Last disclosed trade Apr 28

Every disclosed trade in PCVX by members of Congress under the STOCK Act, parsed by Coldpine. Informational only, sourced from public filings. Not investment advice.

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

Gilbert Cisneros · Bought $PCVX · Apr 28 · $1K–$15K

0.47LOW
Disclosure speedx 0.250.60
Trade sizex 0.250.20
Cluster activityx 0.150.00
Track recordx 0.350.76

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow $PCVX

Get notified when any member of Congress trades $PCVX. Free, no card, no spam.

Follow free →
4
Disclosed trades
3
Buys
1
Sells
2
Members trading

The record on $PCVX

Coldpine has parsed 4 disclosed trades in $PCVX by 2 members of Congress, drawn from 2 periodic transaction reports dated Dec 12, 2022 through Apr 28, 2025. All of them came from House members, all filed by Democrats.

Of the 4 trades with a known filing lag, every one was reported inside the STOCK Act's 45-day window. The median lag was 22 days. The longest was 39 days: a $PCVX sale by Christopher L. Jacobs dated Dec 12, 2022, disclosed Jan 20, 2023. How late filing is measured across all of Congress is in the late-filers study.

Gilbert Cisneros filed the most $PCVX purchases (3), and Christopher L. Jacobs the most sales (1).

Members who trade PCVX

Recent disclosed trades in PCVX

DateMemberTypeAmount
Apr 28Gilbert Cisneros(CA)buy$1K–$15K
Apr 15Gilbert Cisneros(CA)buy$1K–$15K
Apr 14Gilbert Cisneros(CA)buy$1K–$15K
Dec 12Christopher L. Jacobs(NY)sell$1K–$15K

Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores, free with an account →